Financials
- Market Capitalization 419.08 M
- Employee 88
- Founded 1994
- CEO Craig A Tooman
- Website www.silence-therapeutics.com
- Headquarter United Kingdom
- FIGI BBG00WVTHPN2
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-9.65
ratio cours/chiffre d'affaires
1 541.15
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2961 | OVID Ovid Therapeutics Inc. - Common Stock | 2.19 USD | -9.13% | -7.20% | -19.78% | +24.43% | 427.70 M USD | ||
| 2976 | DMAC DiaMedica Therapeutics Inc. - Common Stock | 7.82 USD | -4.63% | -2.37% | +19.39% | +13.33% | 421.70 M USD | ||
| 2983 | TECX Tectonic Therapeutic, Inc. - Common Stock | 21.31 USD | -4.65% | -4.14% | -28.27% | +24.26% | 416.60 M USD | ||
| 2984 | ASMB Assembly Biosciences, Inc. - Common Stock | 20.34 USD | -10.67% | -7.33% | -29.86% | -30.88% | 414.13 M USD |